Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
John B. Kisiel, M.D., focuses his research primarily on the discovery and translation of biomarkers for the early detection of cancer. Collaborating industrywide, Dr. Kisiel's team of multidisciplinary, translational and academic investigators seeks to leverage molecular markers for noninvasive cancer screening and surveillance.
Stool DNA testing has been used to screen for colorectal cancer in over 4 million people. The DNA methylation marker technology used in this test also shows promise for detecting cancers throughout the body when sampled from blood or through other minimally invasive means. Dr. Kisiel and his colleagues are working to develop this technology to noninvasively screen for cancers that are difficult to detect with currently available tools. With this effort, they hope to transform the practice of cancer screening by enabling highly lethal cancers to be found and treated at a curable stage.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.